Docetaxel and S-1 for Advanced Esophageal Cancer
NCT01693432
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Neoplasms
Interventions
DRUG:
DS (docetaxel+S-1)
Sponsor
Hallym University Medical Center
Collaborators
[object Object]